α-突触核蛋白病谱系显性期表型的临床与功能神经影像特征
该横断面研究纳入31例新发PD、32例新发PD合并RBD和30例新发DLB合并RBD患者,通过神经心理测验、[18F]FDG PET和[123I]FP-CIT SPECT比较三组临床与影像特征。结果发现DLB合并RBD患者年龄更大、认知更差且特定脑区代谢减低,而PD患者多巴胺能功能最差;PD合并RBD呈中间表型。
要点
- DLB合并RBD患者认知损害更重,尤其注意、执行和视空间功能。
- DLB合并RBD患者双侧楔前叶、楔叶等脑区葡萄糖代谢显著减低。
- PD患者多巴胺能功能最差,PD合并RBD呈中间表型。
核心结论
- DLB合并RBD与PD不合并RBD分别代表神经元α-突触核蛋白病谱系的两端,PD合并RBD呈中间表型。
研究设计与样本
- 横断面研究,纳入31例新发PD、32例新发PD合并RBD和30例新发DLB合并RBD患者,均接受神经心理测验、[18F]FDG PET和[123I]FP-CIT SPECT检查,诊断依据现行标准并经多巴胺能缺陷和至少2年临床随访确认。
主要发现
- 与PD和PD合并RBD相比,DLB合并RBD患者年龄更大、教育程度更低且认知表现显著更差(p < 0.001),尤其涉及注意、执行和视空间功能。
- DLB合并RBD患者双侧楔前叶、双侧楔叶、右侧角回、右侧后扣带回皮层和右侧梭状回葡萄糖代谢显著减低。
- PD患者多巴胺能功能最差,其较未受累半球(LAH)壳核(p = 0.042)、LAH尾状核(p = 0.027)和受累较重半球(MAH)壳核(p = 0.046)的[123I]FP-CIT结合显著低于PD合并RBD患者,也显著低于DLB合并RBD患者(p = 0.03)。
- DLB合并RBD患者LAH尾状核结合显著低于PD合并RBD患者(p = 0.021)。
- MAH壳核/尾状核比值在PD患者中显著低于PD合并RBD患者(p < 0.001),在PD合并RBD患者中显著低于DLB合并RBD患者(p = 0.002)。
临床怎么用
- 对于新发α-突触核蛋白病患者,应结合RBD状态评估认知、脑葡萄糖代谢和多巴胺能功能,以区分DLB合并RBD、PD合并RBD和PD表型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Dementia with Lewy bodies (DLB) and Parkinson disease (PD), especially when associated with REM sleep behavior disorder (RBD), represent partially overlapping phenotypes of overt α-synucleinopathies. We aimed to investigate overlapping and discrepant features between DLB with RBD (DLBRBD), PD with RBD (PDRBD), and PD without RBD (PD) patients. METHODS: This was a cross-sectional study where consecutive patients with de novo PD, de novo PDRBD, and de novo DLBRBD underwent a full neuropsychological battery to study cognitive impairment, brain [18F]FDG PET as a marker of brain glucose metabolism, and [123I]FP-CIT SPECT as a marker of nigrostriatal dopaminergic functioning. Diagnosis was performed following current criteria, confirmed by evidence of dopaminergic deficit on [123I]FP-CIT SPECT and by at least 2 years of clinical follow-up. RESULTS: We recruited 31 de novo PD (mean age 71.8 ± 6.2; 38.7% females), 32 de novo PDRBD (mean age 72.6 ± 6, 28% females), and 30 de novo DLBRBD (mean age 78 ± 5.4; 40% females). Compared with de novo PD and de novo PDRBD, de novo DLBRBD patients were older, and had a lower education and significantly poorer cognitive performance (p < 0.001), especially involving attention, executive, and visuospatial functions. De novo DLBRBD patients showed significant reduced glucose metabolism involving the bilateral precuneus, bilateral cuneus, right angular gyrus, right posterior cingulate cortex, and right fusiform gyrus. Dopaminergic function was significantly worst in de novo PD, with a significantly lower [123I]FP-CIT binding in the least affected hemisphere (LAH) putamen (p = 0.042), LAH caudate (p = 0.027), and most affected hemisphere (MAH) putamen (p = 0.046) compared with de novo PDRBD patients, which was significantly lower also compared with de novo DLBRBD patients (p = 0.03). De novo DLBRBD had a lower binding compared with de novo PDRBD patients (p = 0.021) in the LAH caudate. The putamen/caudate ratio in the MAH was significantly lower in de novo PD compared with de novo PDRBD patients (p < 0.001) and in de novo PDRBD compared with de novo DLBRBD patients (p = 0.002). DISCUSSION: This study emphasizes how DLB with RBD and PD without RBD represent opposite ends of the neuronal α-synucleinopathy spectrum. The study highlights both overlapping and divergent clinical and neuroimaging features, with PD with RBD patients displaying an intermediate profile.
引用
- Orso B, Mattioli P, Famà F, et al. Uncovering Clinical and Functional Neuroimaging Characteristics of Overt Stage Phenotypes Within the α-Synucleinopathy Spectrum. Neurology. 2025. PMID: 41071970. doi:10.1212/WNL.0000000000214253
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。